Preliminary Results of a Phase I Study of Pharmacological Ascorbate (P-AscH-) with Gemcitabine Chemoradiotherapy in Pancreatic Cancer

被引：1
|
作者：
Wilkes, Justin [1 ]
Allen, Bryan [1 ]
Berg, Daniel J. [1 ]
Wagner, Brett [1 ]
Du, Juan [1 ]
Bodeker, Kellie [1 ]
Ahmann, Logan [1 ]
Vollstedt, Sandy [1 ]
Brown, Heather [1 ]
Alexander, Matthew [1 ]
Cullen, Joseph [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2016年 / 100卷
关键词：
D O I：
10.1016/j.freeradbiomed.2016.10.347
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
306
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [41] Phase II study of gemcitabine in patients with advanced pancreatic cancer
    Carmichael, J
    Fink, U
    Russell, RCG
    Spittle, MF
    Harris, AL
    Spiessi, G
    Blatter, J
    BRITISH JOURNAL OF CANCER, 1996, 73 (01) : 101 - 105
  • [42] A phase II study of gemcitabine and flutamide in advanced pancreatic cancer
    Mayer, A
    Shaw, J
    'Ath, SD
    Price, P
    Blesing, C
    Corrie, P
    BRITISH JOURNAL OF CANCER, 2000, 83 : 18 - 18
  • [43] Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study
    Kamath, Suneel D.
    Kalyan, Aparna
    Kircher, Sheetal
    Nimeiri, Halla
    Fought, Angela J.
    Benson, Al, III
    Mulcahy, Mary
    ONCOLOGIST, 2020, 25 (05): : E808 - E815
  • [44] Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer A Phase II Study
    Safran, Howard
    Miner, Thomas
    Bahary, Nathan
    Whiting, Sam
    Lopez, Charles D.
    Sun, Weijing
    Charpentier, Kevin
    Shipley, Joshua
    Anderson, Elliot
    McNulty, Brendan
    Schumacher, Andrew
    Clark, Alessandra
    Vakharia, Jamsheed
    Kennedy, Teresa
    Sio, Terence
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (01): : 50 - 52
  • [45] Lapatinib and gemcitabine for metastatic pancreatic cancer: A phase II study
    Safran, H.
    Miner, T.
    Bahary, N.
    Whiting, S.
    Lopez, C.
    Sun, W.
    Charpentier, K.
    Charpentier, K.
    Shipley, J.
    Anderson, E.
    McNulty, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Phase I trial of capecitabine and gemcitabine with concurrent radical radiotherapy in locally advanced pancreatic cancer: final results
    Michael, M.
    Price, T.
    Leong, T.
    Ganju, V.
    Strickland, A.
    Jefford, M.
    Ngan, S.
    Milner, A.
    Zalcberg, J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 272 - 272
  • [47] A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer
    Tomao, S
    Romiti, A
    Massidda, B
    Ionta, MI
    Farris, A
    Zullo, A
    Brescia, A
    Santuari, L
    Frati, L
    ANTICANCER RESEARCH, 2002, 22 (04) : 2361 - 2364
  • [48] Gemcitabine (G) in combination radiationtherapy (RT) in stage III-IV pancreatic cancer: First results of a current Phase I study
    Maurer, U
    Stegmeier, P
    Bolte, R
    Jungius, KP
    Mueller, D
    Georgi, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S148 - S148
  • [49] Phase I trial of capecitabine and gemcitabine with concurrent radical radiotherapy in locally advanced pancreatic cancer: interim results
    Leong, T.
    Michael, M.
    Ganju, V.
    Price, T.
    Strickland, A.
    Jefford, M.
    Ngan, S.
    Zalcberg, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 222 - 222
  • [50] A randomized phase II study of axitinib (AG-013736) and gemcitabine versus gemcitabine in advanced pancreatic cancer, preceded by a phase I component
    Spano, J.
    Chodkiewicz, C.
    Maurel, J.
    Wong, R. P.
    Wasan, H. S.
    Pithavala, Y. K.
    Bycott, P. W.
    Liau, K.
    Kim, S.
    Rixe, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345